Akútne a chronické aortové choroby hrudníkovej a brušnej aorty u dospelých
Odporúčania Angiologickej sekcie Slovenskej lekárskej komory pre klasifikáciu a diagnózu chorôb aorty (AS SLK, 2014)

Česká verzia

Authors: Peter Gavorník ^1,2,3; Andrej Dukát ^1,3; Ľudovít Gašpar ^1,2,3
Authors place of work: II. interná klinika LF UK a UN Bratislava, Slovenská republika, prednosta doc. MUDr. Ľudovít Gašpar, PhD. ¹; Prvé angiologické pracovisko (PAP), vedúci lekár doc. MUDr. Peter Gavorník, PhD., mim. prof. ²; Angiologická sekcia Slovenskej lekárskej komory, Slovenská republika, predseda doc. MUDr. Peter Gavorník, PhD., mim. prof. ³
Published in the journal: Vnitř Lék 2015; 61(1): 72-80
Category: Guidelines

Summary

In addition to organovascular arterial ischemic diseases (cardiovascular, vasculovascular, neurovascular, extremitovascular, renovascular, genitovascular, bronchopulmovascular, mesenteriovascular, osteoarthromusculovascular, dermovascular, oculovascular, otovascular, stomatovascular etc.), aortic diseases contribute to the wide spectrum of arterial diseases: aortic aneurysms (AA), acute aortic syndromes (AAS) including aortic dissection (AD), intramural haematoma (IMH), penetrating atherosclerotic ulcer (PAU) and traumatic aortic injury (TAI), pseudoaneurysm, aortic rupture, atherosclerosis, vasculitis as well as genetic diseases (e.g. Turner syndrome, Marfan syndrome, Ehlers-Danlos syndrome) and congenital abnormalities including the coarctation of the aorta (CoA). Similarly to other arterial diseases, aortic diseases may be diagnosed after a long period of subclinical development or they may have an acute presentation. Acute aortic syndrome is often the first sign of the disease, which needs rapid diagnosis and decisionmaking to reduce the extremely poor prognosis. Key clinical-etiology-anatomy-patophysiology (CEAP) diagnostic aspects of aortic diseases are discussed in this document (project Vessels).

Key words:
abdominal aorta – aorta – aortic diseases – arterial system – blood vessels – classification – diagnosis – thoracic aorta

Zdroje

1. Erbel R, Aboyans V, Boileau C et al. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases. Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC). Eur Heart J 2014; 35(41): 2873–2926 .Dostupné z DOI: <http://dx.doi.org/10.1093/eurheartj/ehu281>.

2. Gašpar Ľ. 40. výročie vzniku prvého klinického angiologického pracoviska na Slovensku a 20. výročie založenia Angiologickej sekcie Slovenskej lekárskej komory. Medikom 2014; 4(4): 66–67.

3. Gavorník P. Všeobecná angiológia. Angiologická propedeutika. Cievne choroby. 2nd ed. Univerzita Komenského Vydavateľstvo UK: Bratislava 2001. ISBN 80–223–1608–3.

4. Gavorník P. Angiológia 2 pre všeobecných praktických lekárov. Arteriológia. Dr. Josef Raabe: Bratislava 2014. ISBN 9788081401688.

5. Gavorník P. Projekt Cievy. Cielené vysvetľovanie cievnych chorôb a cievnych porúch. Vnitř Lék 2009; 55(10): 996–997.

6. Olin JW, Gornik HL, Bacharach JM et al. American Heart Association Council on Peripheral Vascular Disease, Council on Clinical Cardiology, Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation, Council on Cardiovascular Disease in the Young, Council on Cardiovascular Radiology and Intervention, Council on Epidemiology and Prevention, Council on Functional Genomics and Translational Biology, Council for High Blood Pressure Research, Council on the Kidney in Cardiovascular Disease, and Stroke Council. Fibromuscular Dysplasia: State of the Science and Critical Unanswered Questions: A Scientific Statement from the American Heart Association. Circulation 2014; 129(9): 1048–1078.

7. Anderson JL, Halperin JL, Albert NM et al. Management of Patients with Peripheral Artery Disease (Compilation of 2005 and 2011 ACCF/AHA Guideline Recommendations): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2013; 127(13): 1425–1443.

8. Arcidiacono MV, Traveset A, Rubinat E et al. Microangiopathy of large artery wall: neglected complication of diabetes mellitus. Atherosclerosis 2013; 228(1): 142–147.

9. Mancia G, Fagard R, Narkiewicz K et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013; 34(28): 2259–2219.

10. Tendera M, Aboyans V, Bartelink ML et al. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries. The Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J 2011; 32(22): 2851–2906.

11. Antignani PL, Benedetti-Valentini F, Aluigi L et al. Diagnosis of vascular diseases. Ultrasound investigations – guidelines. Int Angiol 2012; 31(5 Suppl 1): 1–77.

12. Bays H. Adiposopathy, “sick fat,” Ockham’s razor, and resolution of the obesity paradox. Curr Atheroscler Rep 2014; 16(5): 409.

13. López-Mejías R, Genre F, González-Juanatey C et al. Autoantibodies and biomarkers of endothelial cell activation in atherosclerosis. Vasa 2014; 43(2): 83–85.

14. Papadakis MA, McPhee SJ, Rabow MW (eds). Current Medical Diagnosis and Treatment 2014 (Lange Current Series). 53rd ed. McGraw-Hill Medical: San Francisco 2013. ISBN 978–0071806336.

15. Rydén L, Grant PJ, Anker SD et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. The Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J 2013; 34(39): 3035–3087. Erratum in Eur Heart J 2014; 35(27): 1824.

16. Gavorník P. Končatinovocievne ischemické choroby. In: Gavorník P, Hrubiško M, Rozborilová E (eds). Diferenciálna diagnostika kardiovaskulárnych, respiračných a hematologických ochorení. Dr. Josef Raabe: Bratislava 2010. ISBN 978–80–89182–46–6.

17. Guyatt GH, Akl EA, Crowther M et al. Methodology for the development of antithrombotic therapy and prevention of thrombosis guidelines: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141(2 Suppl): S53-S70.

18. Ip JH, Fuster V, Badimon L et al. Syndromes of accelerated atherosclerosis: Role of vascular injury and smooth muscle cell proliferation. J Am Coll Cardiol 1990; 15(7): 1667–1687.

19. Bergqvist D, Björck M, Lees T et al. Validation of the VASCUNET registry – pilot study. Vasa 2014; 43(2): 141–144.

20. George JN, Nester CM. Syndromes of Thrombotic Microangiopathy. N Engl J Med 2014; 371(7): 654–666.

21. James PA, Oparil S, Carter BL et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014; 311(5): 507–520.

22. Eckel RH, Jakikic JM, Ard JD et al. 2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014; 129(25 Suppl 2): S76-S99. Errata in: Circulation 2014; 129(25 Suppl 2): S100-S101.

23. Fernández MJN, Bermúdez CF, Munñoz DD et al. IgG4-related disease and isolated thoracic aortic aneurysm. Vasa 2014; 43(5): 385–389.

24. Stanley JC, Veith F, Wakefield TW (eds). Current Therapy in Vascular and Endovascular Surgery. 5th ed. Saunders: Philadelphia 2014. ISBN 978–1455709847.

25. Creager MA, Beckman JA, Loscalzo J (eds). Vascular medicine: a companion to Braunwald´s heart disease. 2nd ed. Elsevier/Saunders: Philadelphia 2013. ISBN 9781437729306.

26. Grundy SM, Arai H, Barter P et al. An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia-Full report. Expert Dyslipidemia Panel of the International Atherosclerosis Society. J Clin Lipidol 2014; 8(1): 29–60.

27. Schwarcz AI, Quijano A, Olin JW et al. Internal medicine interns have a poor knowledge of peripheral arterial disease. Angiology 2012; 63(8): 597–602.

28. Gavorník P, Dukát A., Gašpar Ľ. Súčasnosť a budúcnosť farmako-artériotromboprofylaxie v klinickej praxi. Dokument (Odporúčania) Sekcie angiológov Slovenskej lekárskej komory (SA SLK, 2013). Vnitř Lék 2013; 59(12): 1081–1087.

29. Gavorník P, Dukát A, Gašpar Ľ. Manažment stabilnej anginy pectoris a iných foriem chronickej kardiovaskulárnej artériovej choroby. Vnitř Lék 2012; 58(7 a 8): CD29-CD36.

30. Demer LL, Tintut Y. Inflammatory, metabolic, and genetic mechanisms of vascular calcification. Arterioscler Thromb Vasc Biol 2014; 34(4): 715–723.

31. Brown NK, Zhou Z, Zhang J et al. Perivascular adipose tissue in vascular function and disease: a review of current research and animal models. Arterioscler Thromb Vasc Biol 2014; 34(8): 1621–1630.

32. Kramer MHH, Bauer W, Dicker D et al. on behalf of the Working Group on Professional Issues, European Federation of Internal medicine (EFIM). The changing face of internal medicine: Patient centred care. Eur J Intern Med 2014; 25(2): 125–127.

33. Inventory, classification and encyclopeadia of rare diseases, with genes involved. Dostupné z WWW: < http://www.orpha.net/consor/cgi-bin/index.php?lng=EN>.